| | JUNE 20258IN FOCUSPharma giant Lupin Ltd. announced that it has teamed up with Honeywell to develop next-generation inhalers using the latter's propellant, "Solstice Air," to revolutionize respiratory care."Lupin's partnership with Honeywell underscores our commitment to delivering high-quality medicines while working towards a healthier, more sustainable future for our patients and communities worldwide", says Vinita Gupta, CEO Lupin. "By integrating Solstice Air in our products, we are not only enhancing patient care, but we are also significantly reducing environmental impact," adds Vinita.Honeywell's 'Solstice Air', which is intended for people with asthma and chronic obstructive pulmonary disease (COPD), has the ability to stop the production of chemicals with a high global warming potential (GWP), which would be a significant step in lowering carbon emissions, according to the company.As a next-generation propellant for pressurized metered-dose inhalers (pMDIs), Lupin stated that it plans to be the first pharmaceutical business in India to adopt Honeywell's Solstice Air product on a large scale."By continuing to research and develop advanced technologies for reducing carbon, Honeywell is dedicated to driving innovation that enhances the efficacy of health solutions while pioneering emissions reducing practices that support industry advancements."It further stated that Solstice Air provides a substitute for conventional propellants based on hydrofluorocarbons (HFCs), assisting in a 99.9 percent reduction in greenhouse gas emissions.It further stated that the conditions of the agreement are contingent upon the negotiation and execution of final documents that are agreeable to both Honeywell and Lupin. Hon Hai Precision Industry Co. (Foxconn), the main assembler of Apple's iPhones, has committed $1.5 billion to its Indian subsidiary.The investment is said to be made through its Singapore-based unit, according to the reports. In addition to expanding in India, Hon Hai is also said to be investing more in the US.These moves are believed to be part of a broader strategy to reduce exposure to geopolitical risks, including the impact of tariffs on Chinese-made goods.Apple is reportedly seen to be accelerating its efforts to move a major portion of iPhone manufacturing out of China. The move highlights Apple's growing shift toward India amid global supply chain changes.The goal is to produce most of the iPhones sold in the United States from India by the end of March, next year amounting around $22 billion, which is nearly 60 percent increase in output from the previous year. This shift is said to be against the encouragement from the US President Donald Trump, who recently urged Apple CEO Tim Cook to manufacture in America rather than building new factories in India.As there is currently no iPhone manufacturing in the US, the company has pledged to invest $500 billion in the US and increase domestic hiring over the next four years.Minister for Electronics and Information Technology (MeitY) Ashwini Vaishnaw recently announced that Apple exported iPhones worth over rupees 1.5 trillion ($17.4 billion) in the financial year ending March 2025. This marks a significant milestone in Apple's strategy to move manufacturing out of China. LUPIN TEAMS UP WITH HONEYWELL TO DEVELOP NEXT-GENERATION INHALERSHON HAI TO INVEST $1.5 BILLION TO ITS INDIAN SUBSIDIARY
< Page 7 | Page 9 >